How I approach membrane lung dysfunction in patients receiving ECMO.
Bishoy Zakhary, Leen Vercaemst, Phillip Mason...
https://pubmed.ncbi.nlm.nih.gov/33256824/Actively Recruiting
Led by Beijing Chao Yang Hospital · Updated on 2025-06-17
40
Participants Needed
1
Research Sites
N/A
Total Duration
Extracorporeal membrane oxygenation ECMO has been used for over 20 years to support adults with severe respiratory or cardiac failure when conventional treatments are insufficient. This research investigates how membrane lung ML function, crucial for oxygen intake and carbon dioxide removal, may differ at high altitudes compared to low altitudes. The study focuses on whether the known challenges and risks of ML dysfunction during prolonged ECMO support apply similarly in high-altitude regions. The study observes ECMO patients in two locations with different altitudes Beijing at 100 meters and Xining, Qinghai at 2600 meters. Researchers monitor ML function by measuring the partial pressure of post-membrane arterial oxygen and compare the oxygen uptake between these groups. This observational approach helps assess how altitude influences ML function during ECMO support. Participants receiving ECMO support will undergo membrane lung oxygen uptake assessments on the third day of ECMO treatment. Researchers will track outcomes including oxygen transfer efficiency and 60-day mortality rates. The study aims to better understand ML function differences related to altitude, which may guide future ECMO management strategies in various geographic settings.
CONDITIONS
Evaluation of Membrane Lung Function in High-altitude Regions
H
Hua Yang, Dr.
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Beijing Chao Yang Hospital
Lead Sponsor
Affiliated Hospital of Qinghai University
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 60 days
Participants receiving venovenous extracorporeal membrane oxygenation (ECMO) have their membrane lung function monitored at different altitudes.
Initial assessment on the third day of ECMO support and ongoing monitoring up to 60 days
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Bishoy Zakhary, Leen Vercaemst, Phillip Mason...
https://pubmed.ncbi.nlm.nih.gov/33256824/Beijing Chao Yang Hospital
Lead Sponsor
Affiliated Hospital of Qinghai University
Collaborating Sponsor